| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698353 | Clinical Oncology | 2015 | 8 Pages |
Abstract
The rate of single-fraction radiotherapy for bone metastases has remained low in two large Australian institutions, despite considerable evidence that single-fraction treatment provides equivalent pain relief to fractionated therapy. This trend towards fractionated treatment was largely maintained, even in patients with limited life expectancy. Further measures to increase the rate of single-fraction therapy are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.N. Petrushevski, G.S. Gabriel, T.P. Hanna, S. Allen, R.W. Allison, M.B. Barton,